These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 12375026

  • 1. Adenoviral p53 gene therapy in head and neck squamous cell carcinoma cell lines.
    Higuchi Y, Asaumi J, Murakami J, Wakasa T, Inoue T, Kuroda M, Shibuya K, Shigehara H, Kawasaki S, Fukui K, Kishi K, Hiraki Y.
    Oncol Rep; 2002; 9(6):1233-6. PubMed ID: 12375026
    [Abstract] [Full Text] [Related]

  • 2. Thermoradiotherapy combined with adenoviral p53 gene therapy in head and neck squamous cell carcinoma cell lines.
    Higuchi Y, Asaumi J, Murakami J, Matsuzaki H, Wakasa T, Inoue T, Konoucni H, Hisatomi M, Yanagi Y, Honda Y, Shigehara H, Kishi K.
    Oncol Rep; 2003; 10(2):415-20. PubMed ID: 12579282
    [Abstract] [Full Text] [Related]

  • 3. Effects of p53 gene therapy in radiotherapy or thermotherapy of human head and neck squamous cell carcinoma cell lines.
    Higuchi Y, Asaumi J, Murakami J, Matsuzaki H, Wakasa T, Inoue T, Shigehara H, Konouchi H, Hisatomi M, Kawasaki S, Hiraki Y, Kishi K.
    Oncol Rep; 2003; 10(3):671-7. PubMed ID: 12684642
    [Abstract] [Full Text] [Related]

  • 4. Bystander effect in the adenovirus-mediated wild-type p53 gene therapy model of human squamous cell carcinoma of the head and neck.
    Frank DK, Frederick MJ, Liu TJ, Clayman GL.
    Clin Cancer Res; 1998 Oct; 4(10):2521-8. PubMed ID: 9796986
    [Abstract] [Full Text] [Related]

  • 5. Apoptosis induction mediated by wild-type p53 adenoviral gene transfer in squamous cell carcinoma of the head and neck.
    Liu TJ, el-Naggar AK, McDonnell TJ, Steck KD, Wang M, Taylor DL, Clayman GL.
    Cancer Res; 1995 Jul 15; 55(14):3117-22. PubMed ID: 7606733
    [Abstract] [Full Text] [Related]

  • 6. Growth suppression of human head and neck cancer cells by the introduction of a wild-type p53 gene via a recombinant adenovirus.
    Liu TJ, Zhang WW, Taylor DL, Roth JA, Goepfert H, Clayman GL.
    Cancer Res; 1994 Jul 15; 54(14):3662-7. PubMed ID: 8033080
    [Abstract] [Full Text] [Related]

  • 7. In vivo molecular therapy with p53 adenovirus for microscopic residual head and neck squamous carcinoma.
    Clayman GL, el-Naggar AK, Roth JA, Zhang WW, Goepfert H, Taylor DL, Liu TJ.
    Cancer Res; 1995 Jan 01; 55(1):1-6. PubMed ID: 7805018
    [Abstract] [Full Text] [Related]

  • 8. Head and neck squamous cell growth suppression using adenovirus-p53-FLAG: a potential marker for gene therapy trials.
    Overholt SM, Liu TJ, Taylor DL, Wang M, El-Naggar AK, Shillitoe E, Adler-Storthz K, John LS, Zhang WW, Roth JA, Clayman GL.
    Clin Cancer Res; 1997 Feb 01; 3(2):185-91. PubMed ID: 9815671
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of topical gene therapy for head and neck squamous cell carcinoma in an organotypic model.
    Eicher SA, Clayman GL, Liu TJ, Shillitoe EJ, Storthz KA, Roth JA, Lotan R.
    Clin Cancer Res; 1996 Oct 01; 2(10):1659-64. PubMed ID: 9816113
    [Abstract] [Full Text] [Related]

  • 10. [Recombinant adenovirus-p53 gene therapy combined with radiotherapy for head and neck squamous-cell carcinoma].
    Zhang SW, Xiao SW, Liu CQ, Sun Y, Su X, Li DM, Xu G, Zhu GY, Xu B.
    Zhonghua Zhong Liu Za Zhi; 2005 Jul 01; 27(7):426-8. PubMed ID: 16188130
    [Abstract] [Full Text] [Related]

  • 11. All-trans-retinoic acid enhances the effect of adenovirus-mediated wild-type p53 gene transfer in head and neck squamous cell carcinoma.
    Nakashima T, Sun SY, Lotan R, Fujiwara T, Yasumatsu R, Komiyama S, Clayman GL.
    Laryngoscope; 2001 Aug 01; 111(8):1459-64. PubMed ID: 11568584
    [Abstract] [Full Text] [Related]

  • 12. [Effect of E1A gene on in vitro growth inhibition and radiochemosensitivity of lymph node metastasis cells of human head and neck squamous cell carcinoma].
    Wang XL, Qian XL, Zhao QZ, Xu ZG, Tang PZ.
    Ai Zheng; 2003 Nov 01; 22(11):1140-6. PubMed ID: 14613640
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The current status of gene therapy.
    Clayman GL.
    Semin Oncol; 2000 Aug 01; 27(4 Suppl 8):39-43. PubMed ID: 10952437
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of transfection rates on head and neck squamous cell cancer by a novel adenovirus: an in vivo and in vitro study.
    Lalonde ES, Beyer G, Friedlander PL, Kolls JK.
    Head Neck; 2002 Dec 01; 24(12):1038-46. PubMed ID: 12454941
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. p16INK4A adenovirus-mediated gene therapy for human head and neck squamous cell cancer.
    Rocco JW, Li D, Liggett WH, Duan L, Saunders JK, Sidransky D, O'Malley BW.
    Clin Cancer Res; 1998 Jul 01; 4(7):1697-704. PubMed ID: 9676844
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.